Actinium Pharmaceuticals
ATNM
ATNM
50 hedge funds and large institutions have $11.9M invested in Actinium Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 14 increasing their positions, 3 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
27% more capital invested
Capital invested by funds: $9.37M → $11.9M (+$2.54M)
2.13% more ownership
Funds ownership: 8.28% → 10.4% (+2.1%)
Holders
50
Holding in Top 10
–
Calls
$3.47M
Puts
$1.64M
Top Buyers
| 1 | +$1.19M | |
| 2 | +$328K | |
| 3 | +$325K | |
| 4 |
Millennium Management
New York
|
+$188K |
| 5 |
Group One Trading
Chicago,
Illinois
|
+$181K |
Top Sellers
| 1 | -$110K | |
| 2 | -$33K | |
| 3 | -$32.4K | |
| 4 |
William Blair & Company
Chicago,
Illinois
|
-$14.8K |
| 5 |
CAPTRUST Financial Advisors
Raleigh,
North Carolina
|
-$5.68K |